Clinical utility of urine drug screening in children younger than 7 years in the pediatric emergency department: a multicenter retrospective study
Frontiers in Pediatrics · 28.07.2026 · 14
DOI: 10.3389/fped.2026.1859634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 28.07.2026. Verfasst von Renana Gelernter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Emergency Medicine, Shamir Medical Center, Zrifin, Israel. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Urine drug screening (UDS) is an immunoassay frequently used in emergency departments to detect drug exposure; however, its clinical utility remains debated. This study aimed to describe the clinical and epidemiological characteristics of young children who underwent UDS and to assess whether the test results influenced case management.
Methods
We conducted a multicenter retrospective chart review across four hospitals, including children younger than 7 years who underwent UDS between 2010 and 2023.
Results
Among the 693 patients (mean age, 30.7 ± 19.4 months; 59.1% male), 115 UDS tests were positive. In 36 patients (5.2%), the UDS contributed to establishing the diagnosis. Tetrahydrocannabinol (THC) was the most common substance identified in these cases. Hospitalization was more common in the UDS-established diagnosis group (33/36, 91.7% vs. 494/657, 75.2%; P = 0.026), and involvement in child protective services was also more common (26/36, 72.2% vs. 53/657, 8.1%; P < 0.001). The hospitalization duration was shorter in these patients (2.6 ± 2.1 vs. 4.2 ± 6.4 days; P = 0.002), and electroencephalography was performed less often (4/36, 11.1% vs. 229/655, 35.0%; P = 0.003).
Conclusions
UDS influences the diagnosis and management of approximately 5% of young children, most commonly when THC is detected. Further studies are needed to refine the role of UDS in the pediatric emergency department.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Emergency Medicine, Shamir Medical Center, Zrifin, Israel.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Pediatric Emergency Medicine, Ziv Medical Center, Safed, Israel.
- Department of Pediatric Emergency Medicine, Rappaport Faculty of Medicine, Haifa, Israel.
- Technion - Israel Institute of Technology, Haifa, Israel.
- Department of Pediatric Emergency Medicine, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat Gan, Israel.
Zitieren
APA
Gelernter, R., Kozer, E., Hugi-Shitrit, V., Krupik, D., Moskovich, O., Levy, N., Koppel, J. H., & Lurie, Y. (2026). Clinical utility of urine drug screening in children younger than 7 years in the pediatric emergency department: a multicenter retrospective study. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1859634
Vancouver
Gelernter R, Kozer E, Hugi-Shitrit V, Krupik D, Moskovich O, Levy N, et al. Clinical utility of urine drug screening in children younger than 7 years in the pediatric emergency department: a multicenter retrospective study. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1859634
BibTeX
@article{Gelernter2026,
author = {Gelernter, Renana and Kozer, Eran and Hugi-Shitrit, Vered and Krupik, Danna and Moskovich, Or and Levy, Nitai and Koppel, Jordanna H and Lurie, Yael},
title = {Clinical utility of urine drug screening in children younger than 7 years in the pediatric emergency department: a multicenter retrospective study},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1859634}
}
EUVIMED